BlackRock Institutional Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$402M Buy
4,370,095
+104,303
+2% +$8.99M 0.06% 317
2016
Q3
$361M Buy
4,265,792
+77,423
+2% +$6.5M 0.06% 346
2016
Q2
$341M Sell
4,188,369
-12,243
-0.3% -$932K 0.06% 334
2016
Q1
$300M Buy
4,200,612
+286,330
+7% +$19.2M 0.05% 376
2015
Q4
$278M Sell
3,914,282
-94,338
-2% -$6.34M 0.05% 407
2015
Q3
$246M Sell
4,008,620
-46,290
-1% -$3.24M 0.04% 436
2015
Q2
$294M Sell
4,054,910
-205,895
-5% -$15.2M 0.05% 395
2015
Q1
$327M Buy
4,260,805
+144,452
+4% +$10.3M 0.05% 376
2014
Q4
$276M Buy
4,116,353
+20,015
+0.5% +$1.26M 0.04% 414
2014
Q3
$249M Sell
4,096,338
-10,590
-0.3% -$653K 0.04% 431
2014
Q2
$241M Buy
4,106,928
+22,871
+0.6% +$1.34M 0.04% 448
2014
Q1
$237M Buy
4,084,057
+2,752
+0.1% +$147K 0.04% 438
2013
Q4
$219M Sell
4,081,305
-125,860
-3% -$7.46M 0.04% 463
2013
Q3
$260M Sell
4,207,165
-126,509
-3% -$7.57M 0.05% 368
2013
Q2
$263M Buy
+4,333,674
New +$258M 0.05% 361

Other funds holding DGX

BlackRock Institutional Trust's DGX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Quest Diagnostics (DGX) stake by 2.4% in Q4 2016, buying an estimated $8.99M and bringing the position to 4,370,095 shares worth $402M. The position accounts for 0.06% of the portfolio, ranked #317.

BlackRock Institutional Trust first reported a position in DGX in Q2 2013 and has held it in 15 quarters since. 597 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • BlackRock Institutional Trust held 4,370,095 shares of Quest Diagnostics worth $402M as of Q4 2016.
  • BlackRock Institutional Trust bought 104,303 Quest Diagnostics shares in Q4 2016, an estimated $8.99M.
  • Quest Diagnostics made up 0.06% of BlackRock Institutional Trust's portfolio in Q4 2016, its #317 holding.
  • BlackRock Institutional Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 15 quarters since.
  • 597 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.